02/09/2024

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

02/09/2024

Sep 2, 2024, 09:00 | Blog
The Max Foundation's CEO shares a powerful message of commitment honoring those living with CLL
The Max Foundation shared a post on LinkedIn: "Today, our CEO Pat Garcia-Gonzalez shares a…
Sep 2, 2024, 08:57 | Blog
Rasha Aboelhassan: Which maintenance immunotherapy should we choose for stage IV urothelial cancer
Rasha Aboelhassan shared a post on LinkedIn: "Which maintenance immunotherapy should we choose for stage…
Sep 2, 2024, 08:56 | Blog
Han Chong Toh: National Cancer Centre Singapore is raising awareness and funds with Fashion for cancer
Han Chong Toh, Deputy CEO of the National Cancer Centre Singapore, shared a post on…
Sep 2, 2024, 08:47 | Blog
Lisa Lacasse: Helping raise our priorities to candidates through ACSCAN Cancer Vote
Lisa Lacasse shared a post on X by ACSCAN Nevada adding: “Thank you Samantha for…
Sep 2, 2024, 08:43 | Insight
Lewis Au: Preclinical and clinical developments of Bispecific Antibodies
Lewis Au, GU and GI Medical Oncologist at Peter Mac Cancer Centre, shared a post…
Sep 2, 2024, 08:40 | Insight
Durable Responses to Atezolizumab Plus Bevacizumab in HCC
Saadvik Raghuramy shared a post on X about a recent paper by Ying-Chun Shen et…
Sep 2, 2024, 08:40 | Blog
David Braun: We can make a personalized vaccine to target those tumor-specific antigens
Dana-Farber Cancer Institute shared a post on X: “'If we can identify neoantigens specific to…
Sep 2, 2024, 08:38 | Insight
Aaron Goodman: Very rare case of subcutaneous panniculitis T-cell lymphoma
Aaron Goodman shared a post on X about a recent paper by En-Cheng Lin et…
Sep 2, 2024, 08:35 | Insight
Shilpa Gupta: Novel approach of intermittent IO in mRCC
Shilpa Gupta shared a post on X by María Natalia Gandur Quiroga about a recent…
Sep 2, 2024, 08:32 | Insight
Drew Moghanaki: Single fraction lung SBRT has become my go-to for medically inoperable stage I NSCLC
Drew Moghanaki shared a post on X about a paper by Gregory Videtic et al.…
All: 98 Posts: 71 - 80
Special Coverage